Emerging insight of whole genome sequencing coupled with protein structure prediction into the pyrazinamide-resistance signature of Mycobacterium tuberculosis

CK Huang, MC Yu, CS Hung, JC Lin - International Journal of Antimicrobial …, 2024 - Elsevier
Pyrazinamide (PZA) is considered to be a pivotal drug to shorten the treatment of both drug-
susceptible and drug-resistant tuberculosis, but its use is challenged by the reliability of drug …

Pyrazinamide-resistant tuberculosis obscured from common targeted molecular diagnostics

SJ Modlin, M Mansjö, J Werngren, CM Ejike… - Drug Resistance …, 2023 - Elsevier
Here, we describe a clinical case of pyrazinamide-resistant (PZA-R) tuberculosis (TB)
reported as PZA-susceptible (PZA-S) by common molecular diagnostics. Phenotypic …

Resistance To First-Line Antituberculosis Drugs And Prevalence Of pncA Mutations In Clinical Isolates Of Mycobacterium tuberculosis From Zunyi, Guizhou Province …

Z Cao, Y Lan, L Chen, M Xiang, Z Peng… - Infection and drug …, 2019 - Taylor & Francis
Background China is one of the high-burden countries for multidrug-resistant tuberculosis
(MDR-TB), and pyrazinamide is one of the anti-TB drugs used for the shorter MDR-TB …

Mycobacterium tuberculosis Rv0191 is an efflux pump of major facilitator superfamily transporter regulated by Rv1353c

X Li, P Li, C Ruan, L xiang Xie, Y Gu, J Li, Q Yi… - Archives of biochemistry …, 2019 - Elsevier
Abstract Development of extensively drug resistant (XDR) strains and multidrug resistant
(MDR) in Mycobacterium tuberculosis is caused by an efflux mechanism of antibiotics in the …

Exploring of pyrazinamidase recombinant activity from PZA-sensitive and resistant Mycobacterium tuberculosis expressed in Escherichia coli BL21 (DE3)

P Purkan, S Hadi, W Retnowati, S Sumarsih… - Brazilian Journal of …, 2024 - SciELO Brasil
The mutations of pnc A gene encoding pyrazinamidase/PZase in Mycobacterium
tuberculosis are often associated with pyrazinamide/PZA resistance. The H and R1 isolates …

[PDF][PDF] Tuberculosis Epidemiology, Pathogenesis

B Kebede - Drugs and Drug Resistance Development: A Review …, 2019 - researchgate.net
Tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis and
classified as pulmonary and extrapulmonary based on their site of infection. Antituberculosis …

Study of Structurally Diverse Currently Used and Recently Developed Antimycobacterial Drugs

MM Almehmadi, O Abdulaziz, M Halawi… - Medicinal …, 2023 - ingentaconnect.com
Despite major antimicrobial therapeutic advancements, widespread use and misuse of
antimicrobial drugs have increased antimicrobial drug resistance, posing a severe danger to …

Antitubercular drugs: possible role of natural products acting as antituberculosis medication in overcoming drug resistance and drug-induced hepatotoxicity

HK Rana, AK Singh, R Kumar, AK Pandey - … -Schmiedeberg's Archives of …, 2024 - Springer
Mycobacterium tuberculosis (Mtb) is a pathogenic bacterium which causes tuberculosis
(TB). TB control programmes are facing threats from drug resistance. Multidrug-resistant …

[HTML][HTML] Development of TaqMan Duplex Real-time PCR for Simultaneous Detection of Chlamydia Trachomatis and Mycoplasma Genitalium

M Zolfaghari, B Khansarinejad, Z Hamzehloo… - Iranian Journal of …, 2022 - ijmm.ir
S exually transmitted infections (STI) can be caused by pathogens that have been acquired
through sexual activity (1). STIs are the common cause of illness worldwide, and they …

[PDF][PDF] BÚSQUEDA DE GENES IMPLICADOS A LA ALTA RESISTENCIA A PIRAZINAMIDA BASADO EN EL ANÁLISIS TRANSCRIPTÓMICO DE Mycobacterium …

FMM SANCA - repositorio.upch.edu.pe
INTRODUCCIÓN…………………………………………....…….………… 1 2. MARCO
TEÓRICO………………………………………….……….…….... 3 2.1. Mycobacterium …